LobbyingRegenxbio lobbying by quarter
Regenxbio RGNX's latest lobbying report covers Q2 2026, at $180K. The four quarters Q4 2025–Q3 2026 total $460K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Taxation/Internal Revenue Code.
RegenxbioRGNX
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $460K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $130K | 2 |
| Q1 2023 | $223K | 2 |
| Q2 2023 | $150K | 2 |
| Q3 2023 | $154K | 2 |
| Q4 2023 | $141K | 2 |
| Q1 2024 | $15K | 1 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $100K | 2 |
| Q1 2026 | $180K | 3 |
| Q2 2026 | $180K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$434.1K · 17 reports
- Pharmacy$192.5K · 9 reports
- Taxation$174.1K · 10 reports
- Medicare and Medicaid$132.5K · 7 reports
- Copyright, patent and trademark$101.6K · 5 reports
- Immigration$101.6K · 5 reports
- Trade$101.6K · 5 reports
- Medical research and clinical labs$80K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES17 reports
- SENATE17 reports
- Health & Human Services, Dept of (HHS)11 reports
- Executive Office of the President (EOP)6 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Food & Drug Administration (FDA)5 reports
- Homeland Security, Dept of (DHS)5 reports
- Justice, Dept of (DOJ)5 reports
- Patent & Trademark Office (PTO)5 reports
- State, Dept of (DOS)5 reports
- Natl Institutes of Health (NIH)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseRegenxbio | $508K | 5 quarters |
| Knight Capitol Consultants | $305K | 6 quarters |
| LMH Strategic Solutions | $240K | 4 quarters |
| Dla Piper | $160K | 3 quarters |
| Thegroup DC | $120K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter | Q2 2026 |
| SOPHIE KHANAHMADI | Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions | Q1 2026 |
| BRUCE ARTIM | Senate Judiciary Committee Staff Member 1995-2006; (Chief Counsel and Staff Director 2003-04); Intellectual Property Subcommittee - Chief Counsel and Staff Director 2005-06) | Q4 2023 |
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch; Health Policy Director, Senator Orrin G. Hatch | Q4 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Thegroup DC | $60K |
| 07/17for Q2 | Dla Piper | $60K |
| 07/05for Q2 | LMH Strategic Solutions | $60K |
| 04/20for Q1 | Thegroup DC | $60K |
| 04/17for Q1 | LMH Strategic Solutions | $60K |
| 04/16for Q1 | Dla Piper | $60K |
| 02/02for Q1 | Thegroup DC | Under $5,000 |
| 01/16for Q4 2025 | Dla Piper | $40K |
| 01/12for Q4 2025 | LMH Strategic Solutions | $60K |
| 25/12/15for Q4 2025 | Dla Piper | Under $5,000 |
| 25/10/20for Q3 2025 | LMH Strategic Solutions | $60K |
| 25/08/03for Q3 2025 | LMH Strategic Solutions | Under $5,000 |
| 24/04/23for Q1 2024 | Knight Capitol Consultants | $15K |
| 24/01/22for Q4 2023 | Knight Capitol Consultants | $50K |
| 24/01/22for Q4 2023 | In-house | $91K |
| 23/10/16for Q3 2023 | In-house | $94K |
| 23/10/16for Q3 2023 | Knight Capitol Consultants | $60K |
| 23/07/19for Q2 2023 | Knight Capitol Consultants | $60K |
| 23/07/19for Q2 2023 | In-house | $90K |
| 23/04/20for Q1 2023 | Knight Capitol Consultants | $60K |